Medicine and HealthNature Communications
Comprehensive characterization of IFNy signaling in acute myeloid leukemia reveals prognostic and therapeutic strategies
B. Wang, P. K. Reville, et al.
Discover the critical role of interferon gamma (IFNy) in acute myeloid leukemia (AML) through groundbreaking research by Bofei Wang and colleagues. Their work reveals that high levels of IFNy are correlated with venetoclax resistance, suggesting new avenues for treatment strategies against immune evasion in AML patients.
Related Publications
Explore these studies to deepen your understanding
Adjacent work that informs or extends this paper's methodology and findings.
Medicine and Health
Cardiovascular and autonomic dysfunction in long-COVID syndrome and the potential role of non-invasive therapeutic strategies on cardiovascular outcomes
G. Pérez-rubio, R. D. Rio, et al.
Medicine and Health
Serial monitoring of circulating tumour DNA on clinical outcome in myelodysplastic syndromes and acute myeloid leukaemia
X. Zhou, W. Lang, et al.
Medicine and Health
Hyperactive Natural Killer cells in Rag2 knockout mice inhibit the development of acute myeloid leukemia
E. Sugimoto, J. Li, et al.
Medicine and Health
Longitudinal single-cell profiling of chemotherapy response in acute myeloid leukemia
M. M. Naldini, G. Casirati, et al.
